We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Plant Derivative Celastrol Prompts Cancer Cells to Self-Destruct

By LabMedica International staff writers
Posted on 16 Feb 2010
Celastrol, an anti-inflammatory plant derivative long used in Chinese medicine, has been found to have potential as an anticancer drug due to its ability to inhibit the procancer protein p23.

Investigators at the Medical College of Georgia (Augusta, USA) were studying the effect of celastrol on the heat shock protein HSP90, a key modulator of the inflammatory response and linked to both autoimmune diseases and cancer.

They reported in the February 5, 2010, issue of the Journal of Biological Chemistry that celastrol inhibited the Hsp90 chaperoning machinery by inactivating the cochaperone p23, resulting in selective destabilization of steroid receptors. More...
In vitro and in vivo results demonstrated that celastrol disrupted p23 function by altering its three-dimensional structure, leading to rapid formation of amyloid-like fibrils.

"The celastrol induces the protein to form fibrils and clusters it together, which inactivates it,” explained senior author Dr. Ahmed Chadli, professor of biochemistry at the Medical College of Georgia. "When they are clustered, they are not available for other functions that help cancer grow."

"Cancer cells need HSP90 more than normal cells because cancer cells have thousands of mutations,” said Dr. Chadli. "They need chaperones all the time to keep their mutated proteins active. By taking heat shock proteins away from cells, the stabilization is taken away and cell death occurs.”

Related Links:
Medical College of Georgia



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
All-in-One Molecular System
AIO M160
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.